Amylyx Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
AMLX on Nasdaq
Industry
Pharmaceutical Preparations
Location
43 Thorndike Street, Cambridge, MA

Insiders trading volume in the past year

Amylyx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ALS Invest 1 B.V. 10%+ Owner $96.3M Jul 6, 2022
Morningside Venture Investments Ltd 10%+ Owner $81.6M Aug 15, 2023
Dragsa 96 Llc 10%+ Owner $37.6M Jan 11, 2022
Viking Global Investors Lp 10%+ Owner $30.2M Sep 8, 2022
Joshua B. Cohen Co-Chief Executive Officer, Director $10.3M -$232K -2.21% Sep 30, 2024
Margaret Olinger Chief Commercial Officer $5.18M Dec 27, 2023
Justin B. Klee Co-Chief Executive Officer, Director $5M -$232K -4.44% Nov 4, 2024
Patrick D. Yeramian Chief Medical Officer $3.36M -$45.9K -1.35% Jan 9, 2024
George M. Milne Jr Director $1.89M +$220K +13.2% Sep 3, 2024
Camille L. Bedrosian Chief Medical Officer $766K -$66.6K -8% Dec 2, 2024
James M. Frates Chief Financial Officer $620K +$23.5K +3.93% Sep 12, 2024
Gina Mazzariello Chief Legal Officer $456K -$130K -22.1% Sep 30, 2024
Karen Firestone Director $117K +$107K +1000% Sep 5, 2024
Daphne Quimi Director $9.45K +$9.44K +67400% Jun 6, 2024
Bernhardt Zeiher Director Jun 6, 2024
Paul R. Fonteyne Director Jun 6, 2024
Isaac Cheng Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for Amylyx Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.